Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $379.95 | Total: $1,899.75 |
| 1 | 10 | $321.84 | Total: $3,218.40 |
| 1 | 25 | $272.67 | Total: $6,816.75 |
| 1 | 50 | $232.44 | Total: $11,622.00 |
| 1 | 100 | $201.15 | Total: $20,115.01 |
Overview
CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein. CPI-0610 carboxylic acid may have anticancer and anticancer activities.
Chemical Properties
| Molecular Formula | C20H15ClN2O3 |
| Molecular Weight | 366.8 |
| CAS Numbers | 1380089-81-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC=1C=2C=3C(C(=N[C@@H](CC(O)=O)C2ON1)C4=CC=C(Cl)C=C4)=CC=CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Albrecht BK, et al. Identification of a Benzoisoxazoloazepine Inhibitor [CPI-0610] of the Bromodomain and Extra-Terminal [BET] Family as a Candidate for Human Clinical Trials. J Med Chem. 2016;59[4] 1330-1339.